Sign in

CIK 0001787306

  • Large accelerated filer

Arcutis Biotherapeutics, Inc.

Sign in to watch
Ticker
ARQT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812974255
Phone
+1 805-418-5006
Business address
3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE, CA, 91361
Former names
Arcutis, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,253,826
in 9 filings, $2.1M under 10b5-1 plans

Net −$3,253,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-02-09 Watanabe Todd Franklin President and CEO Exercise or conversion +1,000 $1.68 $2K 595,779
2022-02-09 Watanabe Todd Franklin President and CEO Sale −1,000 $17.00 $17K 594,779
2022-02-09 Watanabe Todd Franklin President and CEO Exercise or conversion · Stock Option (Right to Buy) −1,000 119,635
2022-01-05 Watanabe Todd Franklin President and CEO Exercise or conversion +1,000 $1.68 $2K 595,779
2022-01-05 Watanabe Todd Franklin President and CEO Sale −300 $22.40 $7K 595,479
2022-01-05 Watanabe Todd Franklin President and CEO Sale −100 $22.06 $2K 595,379
2022-01-05 Watanabe Todd Franklin President and CEO Sale −600 $21.11 $13K 594,779
2022-01-05 Watanabe Todd Franklin President and CEO Exercise or conversion · Stock Option (Right to Buy) −1,000 120,635
2022-01-03 Matsuda Masaru SVP and General Counsel Grant or award · Stock Option (Right to Buy) +185,000 185,000
2022-01-03 Welgus Howard G. Director Exercise or conversion +2,500 $0.58 $1K 184,396
2022-01-03 Welgus Howard G. Director Sale −2,500 $21.21 $53K 181,896
2022-01-03 Welgus Howard G. Director Exercise or conversion · Stock Option (Right to Buy) −2,500 15,106
2021-12-30 Burnett Patrick Grant or award +16,750 26,250
2021-12-30 Burrows Scott L Chief Financial Officer Grant or award · Stock Option (Right to Buy) +55,704 55,704
2021-12-27 Burrows Scott L Chief Financial Officer Sale −12,560 $20.07 $252K 22,679
2021-12-23 Welgus Howard G. Director Exercise or conversion +2,500 $0.58 $1K 184,396
2021-12-23 Welgus Howard G. Director Sale −2,500 $20.16 $50K 181,896
2021-12-23 Welgus Howard G. Director Exercise or conversion · Stock Option (Right to Buy) −2,500 17,606
2021-12-08 Watanabe Todd Franklin President and CEO Exercise or conversion +1,000 $1.68 $2K 595,779
2021-12-08 Watanabe Todd Franklin President and CEO Sale −1,000 $17.00 $17K 594,779

Page 33 of 35 · 689 trades